# OnCo record alberto-gabizon (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/alberto-gabizon/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "alberto-gabizon" ;
  schema:name "Alberto Gabizon"@en ;
  schema:description "The clinician half of the partnership that turned a liposome chemistry idea into Doxil, and the person who did the trials that showed it behaved differently in patients from free doxorubicin."@en ;
  schema:url <https://onco.cc/people/alberto-gabizon/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://www.szmc.org.il/eng/>, <https://pubmed.ncbi.nlm.nih.gov/?term=Gabizon%20A%5BAuthor%5D%20liposomal%20doxorubicin>, <https://europepmc.org/search?query=AUTH%3A%22Gabizon%20A%22%20AND%20liposomal> ;
  onco:tag "clinician-scientist", "drug-delivery" ;
  schema:jobTitle "Oncologist, Shaare Zedek Medical Center; professor, Hebrew University-Hadassah Medical School" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/kaposi-sarcoma/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/>, <https://onco.cc/fronts/chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/pegylated-liposomal-doxorubicin/>, <https://onco.cc/drugs/doxorubicin/> ;
  onco:institutions <https://onco.cc/institutions/shaare-zedek/>, <https://onco.cc/institutions/hebrew-university-of-jerusalem/> ;
  schema:affiliation <https://onco.cc/institutions/shaare-zedek/> .